Fig. 3: APOLLO11 metadata at the data cut-off of 1st February 2025. | npj Precision Oncology

Fig. 3: APOLLO11 metadata at the data cut-off of 1st February 2025.

From: APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer

Fig. 3: APOLLO11 metadata at the data cut-off of 1st February 2025.The alternative text for this image may have been generated using AI.

A Status of data collection; B Status of centers activation; C RWD metadata; D Radiomics metadata; E FACS analyses. The figure shows the overall status of data collection, divided by type of data collected (A), flowchart of the clinical center contributing to the data collection (B), distribution of patients among characteristics subgroups (Panel C), type of radiological images collected (D), and examples of leukocytes population distribution obtained from FACS analyses (E). CT: computed tomography. eCRF: electronic case report form. IO: immune-oncology treatment. NSCLC non-small cell lung cancer. FACS fluorescence-activated cell sorting. FdG-PET 2-fluorodeoxyglucose positron emission tomography. RWD real-world data. SCLC small cell lung cancer. scRNAseq single-cell ribonucleic acid sequencing. TKI tyrosine kinase inhibitor.

Back to article page